To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The Prognostic Role of LRIG Proteins in Endometrial Cancer
Division of Neonatology, Obstetrics and Gynecology, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Unit of Pathology, Department of Medical Biosciences, Umeå University, Umeå, Sweden.
Division of Neonatology, Obstetrics and Gynecology, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; Institute of Perinatology and Paediatrics, Almazov National Medical Research Centre, St. Petersburg, Russia.
Unit of Pathology, Department of Medical Biosciences, Umeå University, Umeå, Sweden.
Show others and affiliations
2021 (English)In: Cancers, ISSN 2072-6694, Vol. 13, no 6, article id 1361Article in journal (Refereed) Published
Abstract [en]

Endometrial cancer (EC) is the most common gynecologic malignancy in Sweden and it has various prognostic factors. The LRIG family is a group of three integral surface proteins with a similar domain organization. The study aimed to explore LRIG family as prognostic factor proteins in EC. The initial study cohort included 100 women with EC who were treated at the Department of Women’s and Children’s Health, Karolinska University Hospital Solna, between 2007 and 2012. We assessed the associations between LRIG protein expression and type, grade, and stage of EC, as well as progression-free and overall survival. Immunohistochemistry results revealed that most women in the analytical sample had >50% LRIG1-, LRIG2- and LRIG3-positive cells. A statistically significant association was observed between having a high number of LRIG3-positive cells and superior overall survival (incidence rate ratio = 0.977; 95% confidence interval: 0.958–0.996, p = 0.019). Moreover, positive LRIG3 staining of the cell membrane was associated with reducing in the risk of death (hazard ratio = 0.23; 95% confidence interval: 0.09–0.57). Our results show that LRIG3 expression might be a prognostic factor in EC. The role of LRIG1 and LRIG2 expression remains to be further investigated.

Place, publisher, year, edition, pages
MDPI, 2021. Vol. 13, no 6, article id 1361
Keywords [en]
LRIG1, LRIG2, LRIG3, endometrial cancer, prognosis
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:oru:diva-90975DOI: 10.3390/cancers13061361ISI: 000634344300001PubMedID: 33802837Scopus ID: 2-s2.0-85102558250OAI: oai:DiVA.org:oru-90975DiVA, id: diva2:1543932
Funder
Swedish Society for Medical Research (SSMF)
Note

Funding Agency:

Cancer Research Foundation in Northern Sweden  

Available from: 2021-04-13 Created: 2021-04-13 Last updated: 2021-04-16Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Mints, Miriam

Search in DiVA

By author/editor
Mints, Miriam
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
Cancers
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 38 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf